A phase 3, multicenter, randomized, stratified, placebo-controlled, double-blind, parallel group studyto investigate the efficacy and safety of ATL-962 in obese patients with type 2 diabetes anddyslipidemia.

Trial Profile

A phase 3, multicenter, randomized, stratified, placebo-controlled, double-blind, parallel group studyto investigate the efficacy and safety of ATL-962 in obese patients with type 2 diabetes anddyslipidemia.

Completed
Phase of Trial: Phase III

Latest Information Update: 20 May 2016

At a glance

  • Drugs Cetilistat (Primary)
  • Indications Obesity
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 22 Dec 2008 Status changed from not yet recruiting to recruiting according to a Takeda media release.
    • 11 Mar 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top